All live biotherapeutic products (LBPs) articles
-
NewsA review of Clostridioides difficile infection and treatments
<i>Clostridioides difficile</i> is a serious nosocomial infection that could cause from mild diarrhea to fatal colitis. Here presents a general overview that describes the current and emerging treatment practices for the prevention of <i>Clostridioides difficile</i> infection and its recourrences.
-
NewsPHIOGEN announces collaboration with Live UTI Free to drive patient-focused clinical trials
A biotech company developing live biotherapeutic products for drug-resistant and recurrent bacterial infections, is collaborating with a patient research and advocacy organization to empower their clinical development efforts.